Pharma · Private company
GlaxoSmithKline
Track this companyFree. Adds GlaxoSmithKline to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs27From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline27
- Efimosfermin alfaPhase 3 · Metabolic Dysfunction-associated SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- GSK5784283Phase 3 · Pulmonary Disease, Chronic ObstructiveClinicalTrials.gov · fetched Nov 12, 2026
- GSK5784283Phase 3 · Nasal PolypsClinicalTrials.gov · fetched Nov 12, 2026
- GSK5784283Phase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- HFA-134aPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- HFA-152aPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Risvutatug rezetecan (Ris-Rez)Phase 3 · Neoplasms, LungClinicalTrials.gov · fetched Nov 12, 2026
- TopotecanPhase 3 · Neoplasms, LungClinicalTrials.gov · fetched Nov 12, 2026
- BelrestotugPhase 2 · Lung Cancer, Non-Small CellClinicalTrials.gov · fetched Nov 12, 2026
- BepirovirsenPhase 2 · Chronic Hepatitis B Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- BepirovirsenPhase 2 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Daplusiran/Tomligisiran Dose Level 1Phase 2 · Chronic Hepatitis B Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Daplusiran/Tomligisiran Dose Level 2Phase 2 · Chronic Hepatitis B Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- DostarlimabPhase 2 · Lung Cancer, Non-Small CellClinicalTrials.gov · fetched Nov 12, 2026
- EfimosferminPhase 2 · Metabolic Dysfunction-Associated SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- Efimosfermin alfaPhase 2 · Liver Diseases, AlcoholicClinicalTrials.gov · fetched Nov 12, 2026
- GSK5471713Phase 2 · Neoplasms, ProstateClinicalTrials.gov · fetched Nov 12, 2026
- NelistotugPhase 2 · Lung Cancer, Non-Small CellClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Lung Cancer, Non-Small CellClinicalTrials.gov · fetched Nov 12, 2026
- Belantamab mafodotinPhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- BortezomibPhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Efimosfermin alfaPhase 1 · Non-alcoholic Fatty Liver DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- GSK3862995BPhase 1 · Pulmonary Disease, Chronic ObstructiveClinicalTrials.gov · fetched Nov 12, 2026
- LenalidomidePhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- MepolizumabAsthmaClinicalTrials.gov · fetched Nov 12, 2026
- SpirometryAsthmaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple MyelomaPHASE3 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07285239 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)PHASE3 · RECRUITING · started Sep 28, 2026ClinicalTrials.gov NCT07782970 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)PHASE3 · RECRUITING · started Sep 11, 2026ClinicalTrials.gov NCT07780656 · fetched Nov 12, 2026
- A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)PHASE3 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07645248 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)PHASE2 · RECRUITING · started Aug 31, 2026ClinicalTrials.gov NCT07791043 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)PHASE3 · RECRUITING · started Aug 27, 2026ClinicalTrials.gov NCT07782996 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)PHASE3 · RECRUITING · started Aug 27, 2026ClinicalTrials.gov NCT07780669 · fetched Nov 12, 2026
- A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)PHASE3 · RECRUITING · started Jul 22, 2026ClinicalTrials.gov NCT07701993 · fetched Nov 12, 2026
- A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)PHASE3 · RECRUITING · started Jul 22, 2026ClinicalTrials.gov NCT07704892 · fetched Nov 12, 2026
- A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283PHASE1 · ACTIVE_NOT_RECRUITING · started Jul 17, 2026ClinicalTrials.gov NCT07712393 · fetched Nov 12, 2026
- A Study of Efimosfermin Alfa in Adults With Hepatic ImpairmentPHASE1 · RECRUITING · started Mar 13, 2026ClinicalTrials.gov NCT07358546 · fetched Nov 12, 2026
- First-Time-in-Human Study of GSK5471713 in Adults With mCRPCPHASE1_PHASE2 · RECRUITING · started Feb 10, 2026ClinicalTrials.gov NCT07332455 · fetched Nov 12, 2026
- Immunogenicity of RSVPreF3 Vaccine in Immunocompromised PersonsPHASE2 · RECRUITING · started Dec 4, 2025ClinicalTrials.gov NCT07050732 · fetched Nov 12, 2026
- A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]PHASE3 · RECRUITING · started Aug 11, 2025ClinicalTrials.gov NCT07099898 · fetched Nov 12, 2026
- A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHPHASE2 · RECRUITING · started Apr 9, 2025ClinicalTrials.gov NCT06920043 · fetched Nov 12, 2026
- A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 11, 2024ClinicalTrials.gov NCT06537414 · fetched Nov 12, 2026
- Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 17, 2024ClinicalTrials.gov NCT06497504 · fetched Nov 12, 2026
- REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive StudyPHASE4 · ACTIVE_NOT_RECRUITING · started Mar 20, 2024ClinicalTrials.gov NCT06041386 · fetched Nov 12, 2026
- A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary DiseasePHASE1 · ACTIVE_NOT_RECRUITING · started Nov 27, 2023ClinicalTrials.gov NCT06154837 · fetched Nov 12, 2026
- A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 14, 2022ClinicalTrials.gov NCT05565378 · fetched Nov 12, 2026
- A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult ParticipantsPHASE1 · RECRUITING · started Jun 14, 2022ClinicalTrials.gov NCT05418868 · fetched Nov 12, 2026
- Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 14, 2021ClinicalTrials.gov NCT04954859 · fetched Nov 12, 2026
- Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple MyelomaPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 18, 2019ClinicalTrials.gov NCT04091126 · fetched Nov 12, 2026
- Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected AdultsPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 28, 2016ClinicalTrials.gov NCT02951052 · fetched Nov 12, 2026
- Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 21, 2012ClinicalTrials.gov NCT01684397 · fetched Nov 12, 2026